<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>682</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15020763</PubmedId>
            <Abstract>Celiac disease, also known as celiac sprue, is a gluten-induced autoimmune-like disorder of the small intestine, which is strongly associated with HLA-DQ2. The structure of DQ2 complexed with an immunogenic epitope from gluten, QLQPFPQPELPY, has been determined to 2.2-A resolution by x-ray crystallography. The glutamate at P6, which is formed by tissue transglutaminase-catalyzed deamidation, is an important anchor residue as it participates in an extensive hydrogen-bonding network involving Lys-beta71 of DQ2. The gluten peptide-DQ2 complex retains critical hydrogen bonds between the MHC and the peptide backbone despite the presence of many proline residues in the peptide that are unable to participate in amide-mediated hydrogen bonds. Positioning of proline residues such that they do not interfere with backbone hydrogen bonding results in a reduction in the number of registers available for gluten peptides to bind to MHC class II molecules and presumably impairs the likelihood of establishing favorable side-chain interactions. The HLA association in celiac disease can be explained by a superior ability of DQ2 to bind the biased repertoire of proline-rich gluten peptides that have survived gastrointestinal digestion and that have been deamidated by tissue transglutaminase. Finally, surface-exposed proline residues in the proteolytically resistant ligand were replaced with functionalized analogs, thereby providing a starting point for the design of orally active agents for blocking gluten-induced toxicity.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>4175-9</ArticlePages>
            <ArticleTitle>Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Chu-Young</ForeName>
                </Author>
                <Author>
                    <LastName>Quarsten</LastName>
                    <ForeName>Hanne</ForeName>
                </Author>
                <Author>
                    <LastName>Bergseng</LastName>
                    <ForeName>Elin</ForeName>
                </Author>
                <Author>
                    <LastName>Khosla</LastName>
                    <ForeName>Chaitan</ForeName>
                </Author>
                <Author>
                    <LastName>Sollid</LastName>
                    <ForeName>Ludvig M</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA.</Affiliations>
            <ArticleChemicalList>Epitopes;HLA-DQ Antigens;HLA-DQ2 antigen;Ligands;Peptides;Glutens;Gliadin;Proline</ArticleChemicalList>
            <ArticleMeshHeadingsList>Celiac Disease(immunology); Crystallography, X-Ray; Epitopes(chemistry; immunology); Gliadin(chemistry; immunology); Glutens(chemistry; immunology); HLA-DQ Antigens(chemistry; immunology); Humans; Ligands; Peptides(chemistry; immunology); Proline(chemistry); Protein Structure, Tertiary</ArticleMeshHeadingsList>
            <Journal>
                <Volume>101</Volume>
                <Issue>12</Issue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <Issn>0027-8424</Issn>
                <MedlineTa>Proc Natl Acad Sci U S A</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>deamidated gluten epitope Î± I-gliadin</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LQPFPQPQLPY</LinearSequence>
                        <ModifiedResidues>Q8</ModifiedResidues>
                        <Modifications>Deamidation|DEAM</Modifications>
                        <StartingPosition>78</StartingPosition>
                        <EndingPosition>88</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02863.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>4565</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>38944</EpitopeId>
                <ReferenceStartingPosition>78</ReferenceStartingPosition>
                <ReferenceEndingPosition>88</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope positions in SwissProt ID P02863 are 78-88 with one substitution Q85&gt;E.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <MhcBindingId>6693</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>175</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.2</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The structure contains two peptide-MHC complexes. Only one complex (chain IDs: D, E, F) is discussed in the paper.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>314</MhcAlleleId>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1S9V</ComplexPdbId>
                            <MhcChain1PdbChain>D</MhcChain1PdbChain>
                            <MhcChain2PdbChain>E</MhcChain2PdbChain>
                            <EpitopePdbChain>F</EpitopePdbChain>
                            <EpitopeResidues>F: L1, Q2, P3, F4, P5, Q6, P7, E8, L9, P10, Y11</EpitopeResidues>
                            <ViewerFlag>Y</ViewerFlag>
                            <CuratedContacts>
                                <EpitopeResidues>F: L1, Q2, P3, F4, P5, Q6, P7, E8, L9, P10, Y11</EpitopeResidues>
                                <EpitopeResiduesInteractingWithMhc>F: ;</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>E: ; D: ;</MhcResiduesInteractingWithEpitope>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResiduesInteractingWithMhc>F: L1, Q2, P3, F4, P5, Q6, P7, E8, L9, P10, Y11</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>D: Y9, Y22, H24, F51, R52, F54, F58, N62, V65, L66, H68, N69, R76; E: Y9, F11, G13, M14, C15, L26, S28, S30, F47, P56, A57, Y60, W61, I67, K71, R77, V78, H81, N82, L85</MhcResiduesInteractingWithEpitope>
                                <ContactAreaForEpitope>1148.1</ContactAreaForEpitope>
                                <ContactAreaForMhc>811.4</ContactAreaForMhc>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

